Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination. - Revon-Riviere G; Soler C; Andrianarivony T; Fily S; André N (Journal of pediatric hematology/oncology, 2021)